• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

D.Western Therapeutics Institute Inc

+ Add to Watchlist

6DW:GR

17.485 EUR 0.790 4.32%

As of 02:12:49 ET on 08/01/2014.

Company Profile for D.Western Therapeutics Institute Inc (6DW)

D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.

Contact Information

D.Western Therapeutics Institute Inc

1-18-11 Nishiki Naku-ku
Nagoya
Aichi, 460-0003
Japan
Phone: 81-52-218-8785
Fax: 81-52-202-1866

Key Executives for D.Western Therapeutics Institute Inc (6DW)

Hiroyoshi HidakaChairman/Chief Scientist OfcrYuichi HidakaPresident/CEO
Ayako KamikuboDirectorMasakatsu NishikawaDirector
Yoshiyuki YamakawaDirector

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil